Raymond James & Associates’s Cytosorbents Corp CTSO Stock Holding History

Raymond James & Associates’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$75K	Hold	50,000	–	–	﹤0.01%	3767
2024 Q2	$35.2K	Hold	50,000	–	–	﹤0.01%	3784
2024 Q1	$47.5K	Hold	50,000	–	–	﹤0.01%	3768
2023 Q4	$55.5K	Buy	+50,000	New	+$55.5K	﹤0.01%	3656
2022 Q2	–	Sell	-86,500	Closed	-$276K	–	3878
2022 Q1	$276K	Hold	86,500	–	–	﹤0.01%	3437
2021 Q4	$362K	Hold	86,500	–	–	﹤0.01%	3312
2021 Q3	$702K	Hold	86,500	–	–	﹤0.01%	2809
2021 Q2	$653K	Sell	86,500 -131,550	-60%	-$993K	﹤0.01%	2881
2021 Q1	$1.89M	Buy	218,050 +250	+0.1%	+$2.17K	﹤0.01%	2053
2020 Q4	$1.74M	Sell	217,800 -500	-0.2%	-$3.99K	﹤0.01%	1973
2020 Q3	$1.74M	Sell	218,300 -1,500	-0.7%	-$12K	﹤0.01%	1839
2020 Q2	$2.18M	Hold	219,800	–	–	﹤0.01%	1683
2020 Q1	$1.7M	Buy	219,800 +76,500	+53%	+$591K	﹤0.01%	1662
2019 Q4	$552K	Sell	143,300 -76,500	-35%	-$295K	﹤0.01%	2639
2019 Q3	$1.11M	Buy	219,800 +51,000	+30%	+$257K	﹤0.01%	2140
2019 Q2	$1.12M	Hold	168,800	–	–	﹤0.01%	2145
2019 Q1	$1.28M	Hold	168,800	–	–	﹤0.01%	2051
2018 Q4	$1.36M	Buy	168,800 +19,500	+13%	+$158K	﹤0.01%	1894
2018 Q3	$1.93M	Sell	149,300 -18,300	-11%	-$236K	﹤0.01%	1831
2018 Q2	$1.91M	Buy	167,600 +500	+0.3%	+$5.7K	﹤0.01%	1773
2018 Q1	$1.18M	Buy	167,100 +67,100	+67%	+$473K	﹤0.01%	2016
2017 Q4	$650K	Buy	100,000 +50,000	+100%	+$325K	﹤0.01%	2378
2017 Q3	$310K	Hold	50,000	–	–	﹤0.01%	2755
2017 Q2	$215K	Buy	50,000 +24,558	+97%	+$106K	﹤0.01%	2911
2017 Q1	$114K	Sell	25,442 -40,000	-61%	-$179K	﹤0.01%	3015
2016 Q4	$357K	Sell	65,442 -25,000	-28%	-$136K	﹤0.01%	2524
2016 Q3	$579K	Sell	90,442 -234,161	-72%	-$1.5M	﹤0.01%	2165
2016 Q2	$1.48M	Buy	324,603 +247,052	+319%	+$1.12M	﹤0.01%	1507
2016 Q1	$304K	Buy	+77,551	New	+$304K	﹤0.01%	2315
2015 Q4	–	Sell	-128,202	Closed	-$809K	–	2332
2015 Q3	$809K	Buy	+128,202	New	+$809K	﹤0.01%	1699